This is the current revision of this page, as edited by Maxim Masiutin(talk | contribs) at 09:53, 27 January 2024(added display-authors=6 to the main template, removed extra whitespaces). The present address (URL) is a permanent link to this version.
Revision as of 09:53, 27 January 2024 by Maxim Masiutin(talk | contribs)(added display-authors=6 to the main template, removed extra whitespaces)
Hayward CP (1997). "Multimerin: a bench-to-bedside chronology of a unique platelet and endothelial cell protein--from discovery to function to abnormalities in disease". Clinical and Investigative Medicine. 20 (3): 176–87. PMID9189649.
Maurer-Spurej E, Kahr WH, Carter CJ, Pittendreigh C, Cameron M, Cyr TD (2008). "The value of proteomics for the diagnosis of a platelet-related bleeding disorder". Platelets. 19 (5): 342–51. doi:10.1080/09537100802010547. PMID18791940. S2CID31920329.
Polgár J, Magnenat E, Wells TN, Clemetson KJ (1999). "Platelet glycoprotein Ia* is the processed form of multimerin--isolation and determination of N-terminal sequences of stored and released forms". Thromb. Haemost. 80 (4): 645–8. PMID9798985.
Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, et al. (2004). "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides". Nat. Biotechnol. 21 (5): 566–9. doi:10.1038/nbt810. PMID12665801. S2CID23783563.
Hayward CP, Fuller N, Zheng S, Adam F, Jeimy SB, Horsewood I, et al. (2005). "Human platelets contain forms of factor V in disulfide-linkage with multimerin". Thromb. Haemost. 92 (6): 1349–57. doi:10.1160/TH03-02-0123. PMID15583744. S2CID3935661.
Adam F, Zheng S, Joshi N, Kelton DS, Sandhu A, Suehiro Y, et al. (2006). "Analyses of cellular multimerin 1 receptors: in vitro evidence of binding mediated by alphaIIbbeta3 and alphavbeta3". Thromb. Haemost. 94 (5): 1004–11. doi:10.1160/TH05-02-0140. PMID16363244. S2CID84366459.